CA2307705A1 - Modulation de l'inflammation a l'aide de produits du type protease - Google Patents

Modulation de l'inflammation a l'aide de produits du type protease Download PDF

Info

Publication number
CA2307705A1
CA2307705A1 CA 2307705 CA2307705A CA2307705A1 CA 2307705 A1 CA2307705 A1 CA 2307705A1 CA 2307705 CA2307705 CA 2307705 CA 2307705 A CA2307705 A CA 2307705A CA 2307705 A1 CA2307705 A1 CA 2307705A1
Authority
CA
Canada
Prior art keywords
mcp
gelatinase
cells
group
host
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2307705
Other languages
English (en)
Inventor
Ian Clark-Lewis
Christopher Mark Overall
G. Angus Mcquibban
Jiang-Hong Gong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
University of British Columbia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of British Columbia filed Critical University of British Columbia
Priority to CA 2307705 priority Critical patent/CA2307705A1/fr
Priority to CA002316405A priority patent/CA2316405A1/fr
Priority to PCT/CA2001/000741 priority patent/WO2001090361A2/fr
Priority to AU2001261971A priority patent/AU2001261971A1/en
Publication of CA2307705A1 publication Critical patent/CA2307705A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/523—Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1, LDCF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA 2307705 2000-05-26 2000-05-26 Modulation de l'inflammation a l'aide de produits du type protease Abandoned CA2307705A1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CA 2307705 CA2307705A1 (fr) 2000-05-26 2000-05-26 Modulation de l'inflammation a l'aide de produits du type protease
CA002316405A CA2316405A1 (fr) 2000-05-26 2000-08-17 Modulation de l'inflammation a l'aide de produits du type protease
PCT/CA2001/000741 WO2001090361A2 (fr) 2000-05-26 2001-05-25 Modulation des effets de protease sur des substrats de chimiokines
AU2001261971A AU2001261971A1 (en) 2000-05-26 2001-05-25 Modulation of inflammation by protease-treated mcp-3 chemokine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA 2307705 CA2307705A1 (fr) 2000-05-26 2000-05-26 Modulation de l'inflammation a l'aide de produits du type protease

Publications (1)

Publication Number Publication Date
CA2307705A1 true CA2307705A1 (fr) 2001-11-26

Family

ID=4166092

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2307705 Abandoned CA2307705A1 (fr) 2000-05-26 2000-05-26 Modulation de l'inflammation a l'aide de produits du type protease

Country Status (1)

Country Link
CA (1) CA2307705A1 (fr)

Similar Documents

Publication Publication Date Title
EP1061944B1 (fr) Antagonistes therapeutiques du recepteur de chemokine
US6875738B1 (en) Therapeutic chemokine receptor antagonists
US7435718B2 (en) CXCR4 antagonist treatment of hematopoietic cells
AU2001258110B2 (en) Cxcr4 antagonist treatment of hematopoietic cells
WO2000009152A1 (fr) Antagonistes therapeutiques du recepteur de la chimiokine
AU2001258110A1 (en) Cxcr4 antagonist treatment of hematopoietic cells
AU2001252081B2 (en) Cxcr4 agonist treatment of hematopoietic cells
US7378098B2 (en) CXC chemokine receptor 4 agonist peptides
AU778412B2 (en) Vascular endothelial growth factor-X
CA2307705A1 (fr) Modulation de l'inflammation a l'aide de produits du type protease
WO2001090361A2 (fr) Modulation des effets de protease sur des substrats de chimiokines
KR100568755B1 (ko) Ｙｈ 모티프를 포함하는 펩타이드를 유효성분으로함유하는 혈관신생 억제제
JP2004506595A (ja) 血管形成及び心臓血管新生の促進又は阻害
US20050153882A1 (en) Vascular endothelial growth factor-x
CA2322764A1 (fr) Antagonistes therapeutiques du recepteur de chemokine
AU2005201244B2 (en) CXCR4 agonist treatment of hematopoietic cells
CA2305036A1 (fr) Traitement de cellules hematopoietiques a l'aide d'agonistes du cxcr4
Lin CCN3-induced activities in cutaneous wound healing, angiogenesis, and proliferative restenosis
JP2000186045A (ja) 骨吸収抑制剤
CA2408319A1 (fr) Traitement de cellules hematopoietiques base sur des antagonistes du cxcr4
CA2405907A1 (fr) Traitement de cellules hematopoietiques utilisant des agonistes de cxcr4
WO2007053952A1 (fr) Analogues du facteur plaquettaire 4 (pf-4) et leurs utilisations

Legal Events

Date Code Title Description
FZDE Dead